• 1
    Limbago B., Penumalli V., Weinrick B., Scott J.R. ( 2000) Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 68: 638490.
  • 2
    Timmer A.M., Timmer J.C., Pence M.A., Hsu L.C., Ghochani M., Frey T.G., Karin M., Salvesen G.S., Nizet V. ( 2009) Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem 284: 86271.
  • 3
    Sakurai A., Maruyama F., Funao J., Nozawa T., Aikawa C., Okahashi N., Shintani S., Hamada S., Ooshima T., Nakagawa I. ( 2010) Specific behavior of intracellular Streptococcus pyogenes that has undergone autophagic degradation is associated with bacterial streptolysin O and host small G proteins Rab5 and Rab7. J Biol Chem 285: 2266675.
  • 4
    Harder J., Franchi L., Muñoz-Planillo R., Park J.H., Reimer T., Núñez G.J. ( 2009) Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 183: 58239.
  • 5
    Stassen M., Müller C., Richter C., Neudörfl C., Hültner L., Bhakdi S., Walev I., Schmitt E. ( 2003) The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways. Infect Immun 71: 61717.
  • 6
    García-Suárez Mdel M., Cima-Cabal M.D., Flórez N., García P., Cernuda-Cernuda R., Astudillo A., Vázquez F., De los Toyos J.R., Méndez F.J. ( 2004) Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. Infect Immun 72: 453440.
  • 7
    McNeela E.A., Burke A., Neill D.R., Baxter C., Fernandes V.E., Ferreira D., Smeaton S., El-Rachkidy R., McLoughlin R.M., Mori A., Moran B., Fitzgerald K.A., Tschopp J., Pétrilli V., Andrew P.W., Kadioglu A., Lavelle E.C. ( 2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191. doi:10.1371/journal.ppat.1001191.
  • 8
    Shin H.S., Yoo I.H., Kim Y.J., Kim H.B., Jin S., Ha U.H. ( 2010) MKP1 regulates the induction of inflammatory response by pneumococcal pneumolysin in human epithelial cells. FEMS Immunol Med Microbiol 60: 1718.
  • 9
    Yoo I.H., Shin H.S., Kim Y.J., Kim H.B., Jin S., Ha U.H. ( 2010) Role of pneumococcal pneumolysin in the induction of an inflammatory response in human epithelial cells. FEMS Immunol Med Microbiol 60: 2835.
  • 10
    Littmann M., Albiger B., Frentzen A., Normark S., Henriques-Normark B., Plant L. ( 2009) Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression. EMBO Mol Med 1: 21122.
  • 11
    Dessing M.C., Hirst R.A., de Vos A.F., van der Poll T. ( 2009) Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice. PLoS ONE 4: e7993. doi:10.1371/journal.pone.0007993.
  • 12
    Shoma S., Tsuchiya K., Kawamura I., Nomura T., Hara H., Uchiyama R., Daim S., Mitsuyama M. ( 2008) Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation. Infect Immun 76: 154757.
  • 13
    Marriott H.M., Mitchell T.J., Dockrell D.H. ( 2008) Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr Mol Med 8: 497509.
  • 14
    O'Brien D.K., Melville S.B. ( 2004) Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 72: 520415.
  • 15
    Glomski I.J., Gedde M.M., Tsang A.W., Swanson J.A., Portnoy D.A. ( 2002) The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J Cell Biol 156: 102938.
  • 16
    Vadia S., Arnett E., Haghighat A.C., Wilson-Kubalek E.M., Tweten R.K., Seveau S. ( 2011) The pore-forming toxin listeriolysin O mediates a novel entry pathway of L. monocytogenes into human hepatocytes. PLoS Pathog 7: e1002356. doi:10.1371/journal.ppat.1002356.
  • 17
    Dewamitta S.R., Nomura T., Kawamura I., Hara H., Tsuchiya K., Kurenuma T., Shen Y., Daim S., Yamamoto T., Qu H., Sakai S., Xu Y., Mitsuyama M. ( 2010) Listeriolysin O-dependent bacterial entry into the cytoplasm is required for calpain activation and interleukin-1 alpha secretion in macrophages infected with Listeria monocytogenes. Infect Immun 78: 188494.
  • 18
    Tsuchiya K., Kawamura I., Takahashi A., Nomura T., Kohda C., Mitsuyama M.( 2005) Listeriolysin O-induced membrane permeation mediates persistent interleukin-6 production in Caco-2 cells during Listeria monocytogenes infection in vitro. Infect Immun 73: 386977.
  • 19
    Nomura T., Kawamura I., Tsuchiya K., Kohda C., Baba H., Ito Y., Kimoto T., Watanabe I., Mitsuyama M. ( 2002) Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect Immun 70: 104955.
  • 20
    Kayal S., Lilienbaum A., Poyart C., Memet S., Israel A., Berche P. ( 1999) Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Mol Microbiol 31: 170922.
  • 21
    Hamon M.A., Ribet D., Stavru F., Cossart P. ( 2012) Listeriolysin O: the Swiss army knife of Listeria. Trends Microbiol 20: 3608.
  • 22
    Nagamune H., Ohkura K., Sukeno A., Cowan G., Mitchell T.J., Ito W., Ohnishi O., Hattori K., Yamato M., Hirota K., Miyake Y., Maeda T., Kourai H. ( 2004) The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein. Microbiol Immunol 48: 67792.
  • 23
    Hotze E.M., Tweten R.K.( 2012) Membrane assembly of the cholesterol-dependent cytolysin pore complex. Biochim Biophys Acta 1818: 102838.
  • 24
    Ramachandran R., Tweten R.K., Johnson A.E. ( 2004) Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit β-strand alignment. Nat Struct Mol Biol 11: 697705.
  • 25
    Mitchell T.J. ( 2003) The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 1: 21930.
  • 26
    Balachandran P., Hollingshead S.K., Paton J.C., Briles D.E. ( 2001) The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol 183: 310816.
  • 27
    Price K.E., Greene N.G., Camilli A. ( 2012) Export requirements of pneumolysin in Streptococcus pneumoniae. J Bacteriol 194: 365160.
  • 28
    Jefferies J., Nieminen L., Kirkham L.A., Johnston C., Smith A., Mitchell T.J. ( 2007) Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis. J Bacteriol 189: 62732.
  • 29
    Farrand S., Hotze E., Friese P., Hollingshead S.K., Smith D.F., Cummings R.D., Dale G.L., Tweten R.K. ( 2008) Characterization of a streptococcal cholesterol-dependent cytolysin with a Lewis y and b specific lectin domain. Biochemistry 47: 7097107.
  • 30
    Giddings K.S., Zhao J., Sims P.J., Tweten R.K. ( 2004) Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat Struct Mol Biol 11: 11738.
  • 31
    Wickham S.E., Hotze E.M., Farrand A.J., Polekhina G., Nero T.L., Tomlinson S., Parker M.W., Tweten R.K. ( 2011) Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8α and C9. J Biol Chem 286: 2095262.
  • 32
    Gelber S.E., Aguilar J.L., Lewis K.L., Ratner A.J. ( 2008) Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. J Bacteriol 190: 3896903.
  • 33
    Ohkuni H., Todome Y., Okibayashi F., Watanabe Y., Ohtani N., Ishikawa T., Asano G., Kotani S. ( 1997) Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65. FEMS Immunol Med Microbiol 17: 1219.
  • 34
    Ohkuni H., Nagamune H., Ozaki N., Tabata A., Todome Y., Watanabe Y., Takahashi H., Ohkura K., Kourai H., Ohtsuka H., Fischetti V.A., Zabriskie J.B. ( 2012) Characterization of recombinant Streptococcus mitis-derived human platelet aggregation factor. APMIS 120: 5671.
  • 35
    Nagamune H., Ohnishi C., Katsuura A., Fushitani K., Whiley R.A., Tsuji A., Matsuda Y. ( 1996) Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun 64: 3093100.
  • 36
    Bavdek A., Gekara N.O., Priselac D., Gutirrez Aguirre I., Darji A., Chakraborty T., Macek P., Lakey J.H., Weiss S., Anderluh G. ( 2007) Sterol and pH interdependence in the binding, oligomerization, and pore formation of Listeriolysin O. Biochemistry 46: 442537.
  • 37
    Hatanaka M., Seya T., Matsumoto M., Hara T., Nonaka M., Inoue N., Takeda J., Shimizu A. ( 1996) Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Biochem J 314: 96976.
  • 38
    Perrière G., Gouy M. ( 1996) WWW-Query: an on-line retrieval system for biological sequence banks. Biochimie 78: 3649.
  • 39
    Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. ( 2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 29478.
  • 40
    Shimada Y., Maruya M., Iwashita S., Ohno-Iwashita Y. ( 2002) The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur J Biochem 269: 6195203.
  • 41
    Farrand A.J., LaChapelle S., Hotze E.M., Johnson A.E., Tweten R.K. ( 2010) Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci USA 107: 43416.
  • 42
    Ramachandran R., Heuck A.P., Tweten R.K., Johnson A.E. ( 2002) Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nat Struct Mol Biol 9: 8237.
  • 43
    Soltani C.E., Hotze E.M., Johnson A.E., Tweten R.K. ( 2007) Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J Biol Chem 282: 1570916.
  • 44
    Soltani C.E., Hotze E.M., Johnson A.E., Tweten R.K. ( 2007) Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions. Proc Natl Acad Sci USA 104: 2022631.
  • 45
    Kimberley F.C., Sivasankar B., Paul Morgan B. ( 2007) Alternative roles for CD59. Mol Immunol 44: 7381.
  • 46
    Nagamune H., Ohkura K., Umezu K., Shouji H., Kourai H. ( 2004) A cell membrane modification technique using domain 4 of intermedilysin for immunotherapy against cancer. Anticancer Res 24: 336772.
  • 47
    Polekhina G., Giddings K.S., Tweten R.K., Parker M.W. ( 2005) Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc Natl Acad Sci USA 102: 6005.
  • 48
    Ohkura K., Hori H., Nagamune H. ( 2006) Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application. Anticancer Res 26: 405562.
  • 49
    Hughes T.R., Ross K.S., Cowan G.J., Sivasankar B., Harris C.L., Mitchell T.J., Morgan B.P. ( 2009) Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59. Mol Immunol 46: 15617.
  • 50
    LaChapelle S., Tweten R.K., Hotze E.M. ( 2009) Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J Biol Chem 284: 1271926.
  • 51
    Dowd K.J., Tweten R.K. ( 2012) The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly. PLoS Pathog 8: e1002787. doi: 10.1371/journal.ppat.1002787.
  • 52
    Johnson S., Brooks N.J., Smith R.A., Lea S.M., Bubeck D. ( 2013) Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep 3: 136977.